Overexpression of Fc receptor-like 1 associated with B-cell activation during hepatitis b virus infection

Brazilian Journal of Medical and Biological Research

Volumn 45, Issue 12, 2012, Pages 1112-1118

  Wang, Ke ^a   Pei, Hao ^b   Huang, Biao ^a   Yang, Run Lin ^a   Wu, Hang Yuan ^b   Zhu, Xue ^a   Zhu, Lan ^a  

^a BEIJING HOSPITAL   (China)

^b Wuxi Hospital of Infectious Diseases   (China)

Author keywords

B cell activation; Fc receptor like 1; Gene expression; Hepatitis B virus

Indexed keywords

CD19 ANTIBODY; CD69 ANTIGEN; CD86 ANTIGEN; FC RECEPTOR; MESSENGER RNA;

ADULT; ARTICLE; B LYMPHOCYTE ACTIVATION; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HEPATITIS B; HUMAN; HUMAN CELL; MALE; REAL TIME POLYMERASE CHAIN REACTION;

HEPATITIS B VIRUS;

ADULT; B-LYMPHOCYTES; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HEPATITIS B; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, RNA;

EID: 84872317815     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2012007500130     Document Type: Article

References (23)

1. Te HS, Jensen DM. Epidemiology of hepatitis B and C viruses: a global overview. Clin Liver Dis 2010; 14: 1-21, vii.
2. Lledo JL, Fernandez C, Gutierrez ML, Ocana S. Management of occult hepatitis B virus infection: an update for the clinician. World J Gastroenterol 2011; 17: 1563-1568.
3. Vierling JM. The immunology of hepatitis B. Clin Liver Dis 2007; 11: 727-viii.
4. Chisari FV, Isogawa M, Wieland SF. Pathogenesis of hepatitis B virus infection. Pathol Biol 2010; 58: 258-266.
5. Ni YH. Natural history of hepatitis B virus infection: pediatric perspective. J Gastroenterol 2011; 46: 1-8.
6. Nguyen VT, Law MG, Dore GJ. Hepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burden. J Viral Hepat 2009; 16: 453-463.
7. Bertoletti A, Maini MK, Ferrari C. The host-pathogen interaction during HBV infection: immunological controversies. Antivir Ther 2010; 15 (Suppl 3): 15-24.
8. Jung MC, Pape GR. Immunology of hepatitis B infection. Lancet Infect Dis 2002; 2: 43-50.
9. Milich DR, Chen M, Schodel F, Peterson DL, Jones JE, Hughes JL. Role of B cells in antigen presentation of the hepatitis B core. Proc Natl Acad Sci U S A 1997; 94: 14648-14653.
10. Lazdina U, Alheim M, Nystrom J, Hultgren C, Borisova G, Sominskaya I, et al. Priming of cytotoxic T cell responses to exogenous hepatitis B virus core antigen is B cell dependent. J Gen Virol 2003; 84: 139-146.
11. Lazdina U, Cao T, Steinbergs J, Alheim M, Pumpens P, Peterson DL, et al. Molecular basis for the interaction of the hepatitis B virus core antigen with the surface immunoglobulin receptor on naive B cells. J Virol 2001; 75: 6367-6374.
12. Leu CM, Davis RS, Gartland LA, Fine WD, Cooper MD. FcRH1: an activation coreceptor on human B cells. Blood 2005; 105: 1121-1126.
13. Du X, Nagata S, Ise T, Stetler-Stevenson M, Pastan I. FCRL1 on chronic lymphocytic leukemia, hairy cell leukemia, and B-cell non-Hodgkin lymphoma as a target of immunotoxins. Blood 2008; 111: 338-343.
14. Mechetina LV, Najakshin AM, Volkova OY, Guselnikov SV, Faizulin RZ, Alabyev BY, et al. FCRL, a novel member of the leukocyte Fc receptor family possesses unique structural features. Eur J Immunol 2002; 32: 87-96.
15. Ehrhardt GR, Leu CM, Zhang S, Aksu G, Jackson T, Haga C, et al. Fc receptor-like proteins (FCRL): immunomodulators of B cell function. Adv Exp Med Biol 2007; 596: 155-162.
16. Davis RS. Fc receptor-like molecules. Annu Rev Immunol 2007; 25: 525-560.
17. Kazemi T, Asgarian-Omran H, Memarian A, Shabani M, Sharifan RA, Vossough P, et al. Low representation of Fc receptor-like 1-5 molecules in leukemic cells from Iranian patients with acute lymphoblastic leukemia. Cancer Immunol Immunother 2009; 58: 989-996.
18. Kazemi T, Asgarian-Omran H, Hojjat-Farsangi M, Shabani M, Memarian A, Sharifan RA, et al. Fc receptor-like 1-5 molecules are similarly expressed in progressive and indolent clinical subtypes of B-cell chronic lymphocytic leukemia. Int J Cancer 2008; 123: 2113-2119.
19. Farci P, Diaz G, Chen Z, Govindarajan S, Tice A, Agulto L, et al. B cell gene signature with massive intrahepatic production of antibodies to hepatitis B core antigen in hepatitis B virus-associated acute liver failure. Proc Natl Acad Sci U S A 2010; 107: 8766-8771.
20. Wu C, Liu Y, Zhao Q, Chen G, Chen J, Yan X, et al. Soluble CD40 ligand-activated human peripheral B cells as surrogated antigen presenting cells: A preliminary approach for anti-HBV immunotherapy. Virol J 2010; 7: 370.
21. Oliviero B, Cerino A, Varchetta S, Paudice E, Pai S, Ludovisi S, et al. Enhanced B-cell differentiation and reduced proliferative capacity in chronic hepatitis C and chronic hepatitis B virus infections. J Hepatol 2011; 55: 53-60.
22. Bachmann MF, Kopf M. The role of B cells in acute and chronic infections. Curr Opin Immunol 1999; 11: 332-339.
23. Llinas L, Lazaro A, de Salort J, Matesanz-Isabel J, Sintes J, Engel P. Expression profles of novel cell surface molecules on B-cell subsets and plasma cells as analyzed by fow cytometry. Immunol Lett 2011; 134: 113-121.